By improving insulin sensitivity, blood glucose control, blood pressure and overall metabolic health, GLP-1 agonists may help address several underlying drivers of kidney stone disease
Toward a cancer-specific diet
Like any other medications, GLP-1s arent appropriate for every person
A search was conducted using databases of EMBASE, PubMed, Scopus, Cochrane Library, and ISI web of Science from inception to February 2019 without limitations in language
There were significantly more zoospores released by zoosporangia exposed to GSH or GSSG at 24 hr (p=0.0155, 0.0342 respectively), 48 h (p=0.0310, 0.0344 respectively), 66 h (p=0.0063,0.0279 respectively)
Consult a healthcare professional before discontinuing use of GLP-1 medication